TY - JOUR
T1 - Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus
T2 - correlation with calbindin-28k mRNA levels
AU - Kung Sutherland, May
AU - Somerville, Martin J.
AU - Yoong, Larry K.K.
AU - Bergeron, Catherine
AU - Haussler, Mark R.
AU - Crapper McLachlan, Donald R.
N1 - Funding Information:
AcknowledgemenTths.i s researcwha sf unded by a grant from the ScottishR ite FoundatioMn.K S wasa recipient of the Peterbrough-Burgess Alzheimer Society Postdoctoral Feallso wweshllia ps a MRC-ICI Pharma Postdoctoral Fellowship. The authors gratefully acknowledge Dr. R. Tibshirani, Department of Preventative Med-icinea ndB iostatistics, Univerosfit Tyo ronto, fohri s advice and the Canadian Brain Tissue Bank for access to, and bsurapipnl y of, tissue.
PY - 1992/4
Y1 - 1992/4
N2 - Receptors for vitamin D hormone (VDR) and the calcium binding protein, calbindin-28k, have been localized in many tissues, including brain. In brain, VDR and calbindin-28k were reported to colocalize in hippocampal CA1 cells. We have shown that mRNA pool size for calbindin-28k was reduced, on average, by 35% in Alzheimer hippocampal CA1 cells, as compared to Huntington control (manuscript in preparation). In the present study, in situ hybridization with tritiated antisense RNA probes was used to examine VDR expression in paired Alzheimer and Huntington brain tissue. Message levels for VDR were reduced, on average, by 34% and 31%, respectively, in Alzheimer hippocampal CA1 and CA2 pyramidal cells, as compared to Huntington control. However, VDR message levels were not significantly different from control in Alzheimer temporal cortex or cerebellum. There was no correlation between VDR message levels and brain weight, autopsy interval, patient age or the extent of neurofibrillary degeneration. Instead, VDR mRNA pool size in hippocampal CA1 cells correlated significantly with calbindin-28k message levels (r = 0.52, P < 0.001). Decreased message levels for VDR and calbindin-28k in these cells were due to an increased percentage of cells expressing lower message levels for these proteins. These results show that in Alzheimer hippocampal CA1 cells, VDR mRNA pool size is downregulated and that this downregulation may play a role in the reduction of calbindin-28k expression.
AB - Receptors for vitamin D hormone (VDR) and the calcium binding protein, calbindin-28k, have been localized in many tissues, including brain. In brain, VDR and calbindin-28k were reported to colocalize in hippocampal CA1 cells. We have shown that mRNA pool size for calbindin-28k was reduced, on average, by 35% in Alzheimer hippocampal CA1 cells, as compared to Huntington control (manuscript in preparation). In the present study, in situ hybridization with tritiated antisense RNA probes was used to examine VDR expression in paired Alzheimer and Huntington brain tissue. Message levels for VDR were reduced, on average, by 34% and 31%, respectively, in Alzheimer hippocampal CA1 and CA2 pyramidal cells, as compared to Huntington control. However, VDR message levels were not significantly different from control in Alzheimer temporal cortex or cerebellum. There was no correlation between VDR message levels and brain weight, autopsy interval, patient age or the extent of neurofibrillary degeneration. Instead, VDR mRNA pool size in hippocampal CA1 cells correlated significantly with calbindin-28k message levels (r = 0.52, P < 0.001). Decreased message levels for VDR and calbindin-28k in these cells were due to an increased percentage of cells expressing lower message levels for these proteins. These results show that in Alzheimer hippocampal CA1 cells, VDR mRNA pool size is downregulated and that this downregulation may play a role in the reduction of calbindin-28k expression.
KW - Alzheimer's disease
KW - Calbindin-28k
KW - Cerebellum
KW - Hippocampus
KW - Huntington's chorea
KW - In situ hybridization
KW - Temporal cortex
KW - Vitamin D hormone receptor
UR - http://www.scopus.com/inward/record.url?scp=0026597610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026597610&partnerID=8YFLogxK
U2 - 10.1016/0169-328X(92)90032-7
DO - 10.1016/0169-328X(92)90032-7
M3 - Article
C2 - 1317496
AN - SCOPUS:0026597610
SN - 0169-328X
VL - 13
SP - 239
EP - 250
JO - Molecular Brain Research
JF - Molecular Brain Research
IS - 3
ER -